A saliva test could fast track heart attack diagnosis, according to preliminary research. The innovative technique requires patients to spit into a tube and provides results in 10 minutes, compared to at least one hour for the standard blood test.
Chronic pain affects the majority of older adults in the United States, and getting enough exercise plays a key role in pain management. New research suggests that how people think about their pain can have a significant effect on whether they get enough physical activity -- or if they spend more time sedentary.
Most adults with systemic lupus erythematosus (SLE) are not at increased risk of hospitalization from COVID-19 due to medications used to dampen their altered immune system, the cause of their disease.
A study of search engine queries addressed the question of whether online searches for chest pain symptoms correlated to reports of fewer people going to the emergency department with acute heart problems during the COVID-19 pandemic.
Opioid use among women trying to conceive may be associated with a lower chance of pregnancy, suggests a new study. Moreover, opioid use in early pregnancy may be associated with a greater chance of pregnancy loss.
A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment. Patients who could not access their antimalarial drugs faced worse physical and mental health outcomes as a result.
New research shows that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged QTc, key measures of heart rate, in people with rheumatoid arthritis (RA) or systemic lupus erythematosus.
Almost one in five patients with COVID-19 may only show gastrointestinal symptoms, according to a review of academic studies. The findings of the review suggest abdominal radiologists need to remain vigilant during the pandemic while imaging patients.
More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are classified as unexplained and considered cryptogenic sensory polyneuropathy (CSPN). There is no information to guide a physician's drug choices to treat CSPN, but a researcher recently led a first-of-its-kind prospective comparative effectiveness study.
Researchers have carried out the first multi-centered, international, qualitative study exploring the athlete experience (in their own words) of sporting low back pain (LBP). The study found a culture of concealment of pain and injury in rowers, leading to poor outcomes for these athletes.
Autism is considered a disorder of the brain. But a new study suggests that the peripheral nervous system, the nerves that control our sense of touch, pain and other sensations, may play a role as well.
A research team has devised tiny cargo-carrying systems many times smaller than a human hair, made from molecules called peptides that help provide structure for cells and tissues. The team has reported advances in the nanoparticle design that allow them to control the shape of the nanoparticles to allow them to better bind to tissue in the body and stay in a particular location.
Contrary to some claims, people in the US may not be substituting cannabis for opioids, New research examined the direction and strength of association between cannabis and opioid use among adults who used non-medical opioids. The findings showed that opioid use was at least as prevalent on days when cannabis was used as on days when it was not. The study is among the first to test opioid substitution directly.
Researchers report that older adults are increasingly using cannabis to treat a variety of common health conditions, including pain, sleep disturbances and psychiatric conditions like anxiety and depression.
Research shows SARS-CoV-2 promotes pain relief through the receptor neuropilin-1, which gives scientists a new target for non-opioid pain therapeutics and offers one possible explanation for the unrelenting spread of COVID-19.
A mindfulness-based stress reduction course was found to benefit patients with chronic pain and depression, leading to significant improvement in participant perceptions of pain, mood and functional capacity, according to a new study. Most of the study respondents (89%) reported the program helped them find ways to better cope with their pain while 11% remained neutral.